Electrophysiological and histological studies of peripheral nerve were performed in 24 Lewis rats with experimental allergic neuritis (EAN) in A recent review of electrophysiological data taken from the North American study of GBS found that mean distal CMAP amplitude was the most powerful predictor of clinical outcome following treatment by plasma exchange.5 Furthermore, low distal CMAP amplitudes were associated with predispositions to severe disease with increasing probability of poor recovery, a finding that suggests the presence of axonal degeneration. This conclusion, however, which has important consequences for the design and instigation of treatment regimes is superficially at variance with other detailed studies,2 4 in which a low distal amplitude resulted possibly from distal demyelination.
Graham K This study has demonstrated patterns of peripheral nerve conduction impairment similar to those reported in patients with inflammatory demyelinating neuropathy. Moreover, it has shown that a low distal CMAP amplitude may result from demyelination of distal motor nerve segments and not necessarily from axonal degeneration.
Experimental allergic neuritis (EAN) is recognised as the animal model of human GuillainBarre syndrome (GBS) and both diseases share similar clinical, pathological and electrophysiological features.' Prognostic characteristics of GBS are poorly identified. Two distinct patterns of nerve conduction abnormalities have been identified in GBS at least in the early phases of disease. 2 The first is a lengthdependent reduction of the distal compound muscle action potential (CMAP) with relative sparing of sensory potentials that may, when observed in the absence of excessive dispersion, be related to a widespread distribution of demyelinative lesions. 3 The second is a simple reduction of the distal CMAP with little variation in amplitudes generated at different levels of the nerve and which features both motor and sensory nerve impairment. More recently, similar patterns of conduction abnormalities have been identified in chronic inflammatory demyelinating polyneuropathy (CIDP). 4 A recent review of electrophysiological data taken from the North American study of GBS found that mean distal CMAP amplitude was the most powerful predictor of clinical outcome following treatment by plasma exchange.5 Furthermore, low distal CMAP amplitudes were associated with predispositions to severe disease with increasing probability of poor recovery, a finding that suggests the presence of axonal degeneration. This conclusion, however, which has important consequences for the design and instigation of treatment regimes is superficially at variance with other detailed studies,2 4 in which a low distal amplitude resulted possibly from distal demyelination.
This investigation was designed to assess whether demyelination in the distal regions of the peripheral nervous system (PNS) is a common feature of EAN and whether distinct patterns of nerve conduction abnormalities can be identified in EAN similar to those in human GBS and CIDP.
Materials and methods Induction of EAN Twenty four male Lewis rats (body weight 250-320 g) on a standard diet of commercial animal chow and water ad libitum were inoculated with a water-in-oil homogenate of bovine nerve root myelin, sterile saline and Freund's complete adjuvant. The myelin was prepared by discontinuous sucrose density gradient centrifugation similar to the method of Norton and Poduslo (1973).6 The inoculum was prepared by mixing myelin, sterile saline, Freund's incomplete adjuvant (CSL Melbourne, Australia) and Mycobacterium bovis strain AN5 (CSL) in the ratio of 50 mg: 1 ml: 1 ml: 6 mg and homogenising by repeated expulsion between glass syringes coupled with a miniature three way tap. Animals were then anaesthetised using halothane/02 and each given a single subcutaneous injection of 0 1 ml of inoculum into the right footpad. The left footpad remained uninjected. Animals were assessed daily for signs of EAN.
Electrophysiologic studies Animals underwent electrophysiological measurements at day 0 before disease induction and at day 18 post-inoculation. Following anaesthesia using halothane/02, the sciatic nerve was stimulated both proximally and distally through paired stainless steel needle electrodes. One pair was placed to lie alongside the sciatic nerve at the sciatic notch and the other pair was placed at the ankle. The compound muscle action potential was recorded from the small muscles of the feet by another pair of stainless steel needle electrodes. Supramaximal rectangular pulses of 50 ms duration were delivered from an isolated voltage stimulator (Devices Mk IV) triggered by a microcomputer (Apple IIe) at no less than 1 second intervals. Submaximal stimulation strength was used to locate the optimum stimulus electrode site. Signals were pre-amplified by a high input impedance differential amplifier and further amplified to provide an appropriate input for an analogue to digital converter (Applied Engineering 12 bit A/D). Responses were stored and analysed within the microcomputer, displayed on a videomonitor and later stored on floppy disc. For both the injected and uninjected side of each animal proximal and distal latencies were measured using timeintervals from the stimulus artifact to the first negative deflection from baseline. Proximal conduction velocities were calculated using the distances from the sciatic notch to the ankle and the differences between proximal and distal latencies. Amplitudes of the CMAP from both proximal and distal stimulation were also determined. The ratio of CMAIP amplitudes recorded from proximal stimulation to that from distal stimulation was calculated as the R ratio.
Histological studies Directly after completion of electrophysiological measurements on day 18 Comparisons between changes in amplitude expressed as percentage changes from control pre-inoculation readings showed a significantly greater reduction on the injected side compared with the uninjected side (p < 0-001) Action potential amplitudes generated by ankle stimulation were reduced in a similar fashion by 54% compared with control readings (p < 0-001). This decrease was also statistically significandy larger on the injected side compared with the 12% reduction on the uninjected side (p < 0-001). Also in contrast the injected limb showed significant increases in distal latencies (11%, p < 0'001) and decreases in proximal conduction velocities (-12%, p < 0 005). The R ratio was also significantly decreased from pre-inoculation values (-37%, p < 0-001), the injected limb Paterns of conduction impairment in experimental aUergic neuritis. An electrophysiological and histological study Comparisons between SR and LDR groups A summary of histological data presented in 
Discussion
This study confirms the findings of previous electrophysiological studies that CMAPs of peripheral nerves in animals with EAN are characteristically reduced in amplitude and delayed8'0 in a similar fashion to peripheral nerves in GBS.1'-14 Furthermore, this study shows that nerve lesions detectable by electrophysiological and histological examination are a common feature in the distal regions of the PNS in rats with EAN. In animals injected with myelin/FCA in only a single footpad, lesions were detected in the plantar nerves from both inoculated and uninoculated limbs.
In the majority of animals both proximal and distal peripheral nerves were more severely affected in the injected limb compared with the uninjected limb. This observation was based upon electrical studies noting significant differences in proximal and distal CMAP amplitudes, latencies and conduction velocities, and also histological studies in which lesions in transverse nerve sections were assessed in a semi-quantitative fashion. Interestingly, the more severe conduction impairment in inoculated limbs was not simply confined to the distal regions of the PNS in closest proximity to the inoculation site. Whereas distal nerves on inoculated sides were more affected than distal nerves on uninoculated sides, so were more proximal nerve sites well removed from Table 4 Mean histological scores for different levels of grouped sciatic trunks t-for score criteria see Methods.
*-Mann-Whitmey U test p < 0-05.
the site of injection in the foot. This was indicated by differences between sides in proximal conduction velocities and R ratios. Hence, the finding of neurophysiological abnormalities in injected limbs cannot be ascribed simply and solely to recording artifact from foot swelling and nerve compression. Indeed, to avoid this possibility distal nerve segments sampled for histology were removed just proximal to the heel where no obvious swelling could be detected as at the injection site in the footpad. However, the extent to which a local swelling artifact suggested by significantly decreased distal amplitudes contributed to conduction impairment over the length of the sciatic trunk in injected limbs suggested by significantly altered proximal conduction velocities, distal latencies and R ratios is difficult to quantify. This study was supported by the National Multiple Sclerosis Society of Australia.
